Form 4: BioLife Solutions CFO Sells Shares for Tax Obligations
Insider Transaction Report
BioLife Solutions CFO Troy Wichterman sold 584 shares of common stock for $26.74 per share to cover tax withholding obligations.
Summary
- Troy Wichterman, Chief Financial Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
- The transaction involved the disposition of 584 shares of BLFS common stock.
- The shares were sold at a price of $26.74 per share on November 25, 2025.
- The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted by Mr. Wichterman on February 24, 2022.
- The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.
- Following this transaction, Mr. Wichterman beneficially owns 182,769 shares of BioLife Solutions common stock directly.
Sentiment
Score: 5
Explanation: The filing reports a routine, pre-planned insider stock sale for tax withholding purposes, which is a neutral event and does not indicate any change in company fundamentals or management's view of the company's prospects.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, non-discretionary sale for tax purposes by an insider, not indicative of a change in confidence or company performance.
Key Dates
| Date | Description |
|---|---|
| 02-24-2022 | Date Rule 10b5-1(c) trading plan was adopted by Troy Wichterman. |
| 11/25/2025 | Date of transaction (sale of common stock). |
| 11/28/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe reported transaction is a routine, pre-scheduled sale by an insider to cover tax obligations, as disclosed in a Rule 10b5-1 plan. This type of transaction is non-discretionary and does not typically reflect a change in the insider's view of the company's prospects or fundamental value. Therefore, it provides no new information that would warrant a change in investment recommendation.
Keywords
BioLife Solutions, BLFS, Troy Wichterman, Form 4, Insider Trading, Stock Sale, CFO, Tax Withholding, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.